Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Antibe Therapeutics Inc. (ATE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.30 0.00    0.00%
31/12 - Closed. Currency in CAD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.05 / 0.30
  • Day's Range: 0.28 - 0.34
Type:  Equity
Market:  Canada
Antibe Therapeutics Inc. 0.30 0.00 0.00%

ATE Financial Summary

 
A brief financial summary of Antibe Therapeutics Inc. as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

For the nine months ended 31 December 2021, Antibe Therapeutics Inc revenues decreased from C$6.8M to C$0K. Net loss before extraordinary items increased 6% to C$20M. Revenues reflect Citagenix segment decrease of 60% to C$2.7M, Canada segment decrease of 58% to C$1.3M, United States segment decrease of 66% to C$845K. Higher net loss reflects Stock-based Compensation in SGA increase of 76% to C$3.1M (expense).

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ATE Income Statement

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Total Revenue 0 0 0 2.95
Gross Profit 1.08 1.04
Operating Income -5.23 -8.39 -6.45 -5.96
Net Income -4.85 -8.68 -6.3 -5.97

ATE Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ 10.06
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Total Assets 92.47 95.86 102.86 81.74
Total Liabilities 31.24 31.21 31.13 31.48
Total Equity 61.22 64.64 71.73 50.26

ATE Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  -364.27%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Period Length: 9 Months 6 Months 3 Months 12 Months
Cash From Operating Activities -13.15 -11.31 -4.94 -0.1
Cash From Investing Activities -0.24 -0.24 -0.21 -0.26
Cash From Financing Activities 0.01 0.05 -0.04 66.16
Net Change in Cash -13.38 -11.49 -5.18 65.79
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ATE Comments

Write your thoughts about Antibe Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mark wiz
Mark wiz Feb 25, 2021 14:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Take the L sell that sht
Mark wiz
Mark wiz Feb 25, 2021 14:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Antibe sux ass
Mac McGILL
Mac McGILL Dec 01, 2020 15:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It would have been nice to get the heads up yesterday
dion guemos
dion guemos Dec 01, 2020 13:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wtf happened here?
Tyler James
Tyler James Jul 17, 2020 23:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
time to sell
Daniel Borges
Daniel Borges Apr 14, 2020 17:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
warrants, derisking before results
Csilla Cziriak
Csilla Cziriak Apr 14, 2020 14:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anybody knows why ATE is falling?
Lou Perri
Lou Perri Apr 07, 2020 5:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy out coming soon
Csilla Cziriak
Csilla Cziriak Jan 30, 2020 14:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Does anybody know why the stock ran up?
Harvey Chernoff
Harvey Chernoff Jan 30, 2020 14:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
results of phase 2 study should be coming available soon...
Harvey Chernoff
Harvey Chernoff Jan 30, 2020 14:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
results of phase 2 study should be coming available soon...
Harvey Chernoff
Harvey Chernoff Jan 30, 2020 14:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
results of phase 2 study should be coming available soon...
Harvey Chernoff
Harvey Chernoff Jan 30, 2020 14:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
results of phase 2 study should be coming available soon...
Ellwin Yu
Ellwin Yu Oct 18, 2019 15:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email